The role of tumor necrosis factor in sepsis
dc.contributor.author | Spooner, Christopher E. | en_US |
dc.contributor.author | Markowitz, Norman P. | en_US |
dc.contributor.author | Saravolatz, Louis D. | en_US |
dc.date.accessioned | 2006-04-10T15:27:15Z | |
dc.date.available | 2006-04-10T15:27:15Z | |
dc.date.issued | 1992-01 | en_US |
dc.identifier.citation | Spooner, Christopher E., Markowitz, Norman P., Saravolatz, Louis D. (1992/01)."The role of tumor necrosis factor in sepsis." Clinical Immunology and Immunopathology 62(1, Part 1): S11-S17. <http://hdl.handle.net/2027.42/30380> | en_US |
dc.identifier.uri | http://www.sciencedirect.com/science/article/B6WCK-4C894RY-2F/2/f30dd9df322e294d3fe54618d10a8114 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/30380 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=1370262&dopt=citation | en_US |
dc.description.abstract | There is an increasing incidence of sepsis among hospitalized patients. Also, high mortality associated with sepsis and septic shock persists despite appropriate antibiotic therapy. Recent investigations have demonstrated that bacterial antigens stimulate a cascade of cellular mediators or cytokine release. In sepsis and septic shock the response of these cytokines often exceeds natural downregulation and leads to multisystem organ failure and even death in an unacceptably high number of patients. Many investigative studies have shown that tumor necrosis factor (TNF) is the prime mediator of the inflammatory response seen in sepsis and septic shock. Sepsis management in the future will include immune modulating therapy directed against the deleterious effects of cytokines, specifically TNF. This article reviews the current problem of sepsis and the evidence to support the role of TNF in sepsis. Also, recent studies employing monoclonal antibodies against TNF as well as considerations for future studies are discussed. | en_US |
dc.format.extent | 1029102 bytes | |
dc.format.extent | 3118 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.language.iso | en_US | |
dc.publisher | Elsevier | en_US |
dc.title | The role of tumor necrosis factor in sepsis | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Microbiology and Immunology | en_US |
dc.subject.hlbsecondlevel | Internal Medicine and Specialties | en_US |
dc.subject.hlbtoplevel | Science | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | University of Michigan Medical School, Ann Arbor, Michigan 48109, USA; Division of Infectious Diseases and Hospital Epidemiology, Henry Ford Hospital, Detroit, Michigan 48202, USA | en_US |
dc.contributor.affiliationum | University of Michigan Medical School, Ann Arbor, Michigan 48109, USA; Division of Infectious Diseases and Hospital Epidemiology, Henry Ford Hospital, Detroit, Michigan 48202, USA | en_US |
dc.contributor.affiliationum | University of Michigan Medical School, Ann Arbor, Michigan 48109, USA; Division of Infectious Diseases and Hospital Epidemiology, Henry Ford Hospital, Detroit, Michigan 48202, USA | en_US |
dc.identifier.pmid | 1370262 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/30380/1/0000782.pdf | en_US |
dc.identifier.doi | http://dx.doi.org/10.1016/0090-1229(92)90036-N | en_US |
dc.identifier.source | Clinical Immunology and Immunopathology | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.